C-J Lin, K-H Li, J-F Hwang, S-N Chen. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/drug therapyAdenocarcinoma/pathologyAdenocarcinoma/secondaryAdultAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabChoroid Neoplasms/drug therapyChoroid Neoplasms/pathologyChoroid Neoplasms/secondaryColonic NeoplasmsHumansIntravitreal InjectionsMaleTreatment OutcomeVisual Acuity
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2009 PMID: 19893587 DOI: 10.1038/eye.2009.257
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775